SEC 13F Intelligence

Hartford Investment Management Co / ABBV

Hartford Investment Management Co’s Abbvie Inc Position

Does Hartford Investment Management Co own Abbvie Inc (ABBV)? Yes97.6K shares worth $25M (+0.70% of its 13F portfolio) as of Q2 2026, down from 100.7K shares the prior filed quarter.

Position Value
$25M
Q2 2026
Shares
97.6K
% of Portfolio
+0.70%
Quarters Held
31
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $16MQ4 ’18Q1 ’19: $14MQ2 ’19: $13MQ3 ’19: $13MQ4 ’19: $15MQ4 ’19Q1 ’20: $13MQ2 ’20: $19MQ3 ’20: $16MQ4 ’20: $22MQ4 ’20Q1 ’21: $22MQ2 ’21: $22MQ3 ’21: $19MQ4 ’21: $26MQ4 ’21Q1 ’22: $29MQ2 ’22: $28MQ3 ’22: $24MQ4 ’22: $29MQ4 ’22Q1 ’23: $24MQ2 ’23: $17MQ3 ’23: $18MQ4 ’23: $18MQ4 ’23Q1 ’24: $21MQ2 ’24: $19MQ3 ’24: $22MQ4 ’24: $19MQ4 ’24Q1 ’25: $23MQ2 ’25: $20MQ3 ’25: $24MQ4 ’25: $23MQ4 ’25Q1 ’26: $22MQ2 ’26: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202697.6K$25M+0.70%
Q1 2026100.7K$22M+0.69%
Q4 2025102.1K$23M+0.70%
Q3 2025103.5K$24M+0.72%
Q2 2025106.6K$20M+0.63%
Q1 2025107.7K$23M+0.78%
Q4 2024109.2K$19M+0.64%
Q3 2024111.2K$22M+0.72%
Q2 2024113.1K$19M+0.67%
Q1 2024114.1K$21M+0.73%
Q4 2023118.9K$18M+0.69%
Q3 2023121.4K$18M+0.72%
Q2 2023124.9K$17M+0.63%
Q1 2023150.0K$24M+0.81%
Q4 2022181.7K$29M+0.89%
Q3 2022182.5K$24M+0.79%
Q2 2022180.8K$28M+0.85%
Q1 2022176.4K$29M+0.74%
Q4 2021188.7K$26M+0.59%
Q3 2021174.3K$19M+0.52%
Q2 2021195.3K$22M+0.55%
Q1 2021199.6K$22M+0.57%
Q4 2020206.2K$22M+0.59%
Q3 2020185.0K$16M+0.55%
Q2 2020191.9K$19M+0.67%
Q1 2020175.2K$13M+0.46%
Q4 2019172.9K$15M+0.39%
Q3 2019176.6K$13M+0.38%
Q2 2019181.3K$13M+0.37%
Q1 2019179.7K$14M+0.41%
Q4 2018175.8K$16M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hartford Investment Management Co’s full portfolio or all institutional holders of ABBV.